IBM: Quantum Advantage Is Not a Race, but a Business Strategy
Quantum advantage — a term often perceived as an absolute technological frontier. However, as a new report from the IBM Institute for Business Value shows, the reality is far more complex and interesting. In their study "Journey to Quantum Advantage," the company shifts focus from abstract benchmarks to practical value. According to analysts, quantum advantage is not a single finish line for everyone, but the ability to solve specific business problems more accurately, faster, or cheaper than classical methods.
The report, based on interviews with leaders from aerospace, finance, biomedicine, energy, and the public sector, paints a picture of a maturing understanding: early adopters are already evaluating quantum systems through the lens of applied scenarios. This is a fundamental shift from the race for qubits to the search for real value.
Three reasons to enter the quantum era
IBM highlights three key motivations driving business:
- Solving complex business problems — 60% of respondents.
- Future-proofing computing strategy — 55%.
- Accelerating innovation — 54%.
However, the path to quantum readiness is fraught with challenges. The main barriers are not just the "rawness" of the technology. The top issues are:
- Acute shortage of quantum skills — 61%.
- Technology immaturity — 56%.
- Unclear timelines for the emergence of applied scenarios — 46%.
Companies face tough questions about return on investment, the need for in-house expertise, and selecting tasks where quantum methods can truly deliver measurable results, rather than just looking impressive.
Real-world cases: From Boeing to biomedicine
The report is rich with illustrative examples. Boeing sees potential not in technological records, but in quantum chemistry and materials science for aircraft design and certification. Since 2022, Vanguard has been experimenting with hybrid approaches for anti-money laundering and portfolio optimization. E.ON, after testing quantum methods, encountered limitations of current hardware and adjusted its roadmap toward long-term preparation. Bosch, having gone through noisy early demonstrations, has focused on algorithms for future fault-tolerant systems.
In biomedicine, Yonsei University uses quantum resources in conjunction with classical supercomputers to accelerate drug development. Even a 10-20% reduction in the 15-year cycle represents a colossal breakthrough. Meanwhile, the Quantum Pangenomics team from the Wellcome Sanger Institute and the University of Oxford has already loaded the complete genome of the hepatitis D virus onto the 156-qubit IBM Heron processor.
The ecosystem as an engine
IBM emphasizes the critical role of partnerships between business, government, and academia. One in two "quantum-ready" organizations already participates in such collaborations. The current market stage is a period of experimentation, capability building, and preparation for future applied scenarios. Quantum advantage will not arrive for everyone at once, and it has not yet become a mainstream tool.
Expert opinion: The IBM report is a sobering and highly timely document. It shatters the illusion that quantum computers are about to replace classical ones. The reality is that the key asset today is not so much the hardware itself, but the "quantum literacy" of a business — the ability to formulate a problem, find a partner, and assess return on investment. Companies that are already investing in competencies and ecosystems, rather than just waiting for a "magic button," will gain a tremendous advantage when the technology matures.